查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726274

全球电子药物输送设备市场：市场规模、份额、趋势分析（按产品、应用和地区）、细分市场预测（2025-2030 年）

Electronic Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product (Implantable Drug Delivery Devices, Smart Metered Dose Inhalers), By Application (Diabetes, Oncology), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10个工作天内

价格

电子药物传输设备市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球电子药物输送设备市场规模预计到2030年将达到995亿美元，2025年至2030年期间的复合年增长率为8.14%。

这种增长可以归因于老年人口的增长和慢性病的流行、个人化医疗意识的增强、居家医疗的日益普及以及数位技术的融合。例如，2024 年 6 月，AptarGroup, Inc. 与 SHL Medical 合作，将 Aptar Digital Health 的 SaMD 平台与 SHL Medical 的先进药物输送系统（包括自动注射器、笔式註射器和专用输送系统）结合。

随着患者越来越倾向于在家中管理自己的健康状况，对能够安全、有效和轻鬆地在家中进行治疗的药物输送装置的需求也日益增加。胰岛素帮浦、自动注射器、穿戴式输液帮浦和预填充式注射器等设备正在成为居家医疗的必备工具，因为它们允许患者在最少的帮助下自行用药，既方便又自主。例如，2023 年 10 月，以其创新的 PEEK生医材料而闻名的 Victrex plc 推出了其 VICTREX PC101 级产品，这是一款专为药物输送和药物接触应用而设计的先进产品。此次发布反映了家庭护理环境中药物输送设备日益增长的趋势，增加了寻求创新解决方案的患者的可及性。

此外，由于对更高精度、个人化和患者便利性的需求，电子药物输送设备市场技术趋势正在快速发展。新兴趋势包括数位健康技术的整合、穿戴式药物传输设备以及微流体的使用。精准医疗的兴起也正在推动技术创新。电子药物传输装置可以根据个人的基因组成、医疗状况或特定的治疗需求进行定制，以确保更好的治疗效果和更少的副作用。

电子药物输送设备市场：分析概述

  • 根据产品，植入式药物输送装置占据市场主导地位，2024 年的收入份额最大，为 33.0%，这得益于其减少副作用、控製药物释放和提供局部治疗的能力。
  • 根据应用，糖尿病领域预计将在 2024 年占据最大的收益占有率。这是由于糖尿病盛行率高且患者数量不断增加、糖尿病治疗技术进步、市场需求不断增加以及报销支持。
  • 按地区划分，预计 2024 年北美将占据最大的收益占有率，超过 43.4%。这是由于技术进步、慢性病盛行率上升以及对以患者为中心的药物输送解决方案的需求不断增长。

目录

第一章 分析方法与范围

第二章执行摘要

3. 电子药物传输设备市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 关键科技趋势
  • 主要品牌
  • 管道分析
  • 电子药物输送设备市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL分析

第四章电子药物输送设备市场：按产品分類的估计和趋势分析

  • 细分仪表板
  • 电子药物输送设备市场：产品特定波动分析
  • 电子药物传输设备市场：产品展望
  • 市场规模预测及趋势分析（2018-2030年）
  • 智慧型输液帮浦（输液系统）
  • 智慧定量吸入器（吸入装置）
  • 植入式药物传输装置

第五章电子药物传输设备市场：按应用的估计和趋势分析

  • 细分仪表板
  • 电子药物传输设备市场：应用趋势分析
  • 电子药物传输设备市场：应用前景
  • 市场规模预测及趋势分析（2018-2030年）
  • 糖尿病
  • 呼吸系统疾病
  • 肿瘤学
  • 心臟病学
  • 其他的

第六章电子药物传输设备市场：区域估计与趋势分析

  • 区域仪表板
  • 电子药物输送设备市场：区域波动分析
  • 电子药物输送设备市场：区域估计与趋势分析
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 市场参与企业分类
  • 主要企业简介
    • Medtronic plc
    • Insulet Corporation
    • Becton, Dickinson and Company
    • Tandem Diabetes Care, Inc.
    • Ypsomed AG
    • Novo Nordisk A/S
    • Sanofi SA
    • Eli, Lilly and Company
    • AstraZeneca plc
    • GlaxoSmithKline plc
    • Boehringer Ingelheim International GmbH
    • Pfizer, Inc.
    • Teva Pharmaceutical Industries
    • Phillips-Medisize, LLC
    • West Pharmaceutical Services, Inc.
    • Gerresheimer AG
    • Nemera Group
    • SHL Group
    • Owen Mumford
    • Haselmeier AG
    • ICU Medical
    • Hisamitsu Pharmaceutical Co., Inc.
    • Sparsha Pharma International
    • Baxter International, Inc.
    • Fresenius Kabi AG
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Novartis AG
    • AptarGroup, Inc.
    • Teleflex Incorporates
    • Abbott Laboratories
Product Code: GVR-4-68040-556-9

Electronic Drug Delivery Devices Market Growth & Trends:

The global electronic drug delivery devices market size is anticipated to reach USD 99.5 billion by 2030 and is anticipated to grow at a CAGR of 8.14% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the increasing the growing geriatric population and prevalence of chronic diseases, increasing awareness for personalized medicine, rising preference for home healthcare, and the integration of digital technologies. For instance, in June 2024, AptarGroup, Inc. collaborated with SHL Medical to integrate Aptar Digital Health's SaMD platform with SHL Medical's advanced drug delivery systems, such as autoinjectors, pen injectors, and specialty delivery systems.

As patients are increasingly preferring to manage their health conditions at home, there is a growing demand for drug delivery devices that enable safe, effective, and easy at-home treatments. Devices such as insulin pumps, auto-injectors, wearable infusion pumps, and pre-filled syringes are becoming indispensable tools in home healthcare because they allow patients to self-administer medications with minimal assistance, offering both convenience and autonomy. For instance, in October 2023, Victrex plc, known for its innovative PEEK biomaterial solutions, introduced an advanced product, the VICTREX PC101 grade, specifically designed for drug delivery and pharmaceutical contact applications. This launch aligns with the growing trend of utilizing drug delivery devices in homecare environments, enhancing accessibility for patients seeking innovative solutions.

Moreover, technology trends in the electronic drug delivery devices market are rapidly advancing, driven by the need for greater precision, personalization, and patient convenience. Some of the new trends include the integration of digital health technologies, wearable drug delivery devices, and the use of microfluidics. The rise of precision medicine is also driving innovation. The devices are being tailored to the individual's genetic makeup, condition, or specific therapeutic needs, ensuring better outcomes and fewer side effects.

Electronic Drug Delivery Devices Market Report Highlights:

  • Based on product, the implantable drug delivery devices segment dominated the market with the largest revenue share of 33.0% in 2024 owing to reduced side effects, controlled drug release, and their ability to provide localized treatment.
  • Based on application, the diabetes segment accounted for the largest revenue share in 2024 due to its high prevalence and growing patient population, technological advancements in diabetes care, growing market demand, and reimbursement support.
  • Based on region, North America held the largest revenue share of over 43.4% in 2024. This can be attributed to technological advancements, an increasing prevalence of chronic diseases, and rising demand for patient-centric drug delivery solutions.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Electronic Drug Delivery Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases and growing geriatric population
      • 3.2.1.2. Rising preference for home healthcare
      • 3.2.1.3. Integration of digital technologies and growing awareness of personalized medications
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of advanced drug delivery devices
      • 3.2.2.2. Limited patient awareness and device-related complications
  • 3.3. Key Technology Trends
  • 3.4. Key Brands
  • 3.5. Pipeline Analysis
  • 3.6. Electronic Drug Delivery Devices Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Bargaining power of suppliers
      • 3.6.1.2. Bargaining power of buyers
      • 3.6.1.3. Threat of substitutes
      • 3.6.1.4. Threat of new entrants
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Economic landscape
      • 3.6.2.3. Social landscape
      • 3.6.2.4. Technological landscape
      • 3.6.2.5. Environmental landscape
      • 3.6.2.6. Legal landscape

Chapter 4. Electronic Drug Delivery Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Electronic Drug Delivery Devices Market: Product Movement Analysis
  • 4.3. Electronic Drug Delivery Devices Market by Product Outlook (Revenue, USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Smart Infusion Pumps (Infusion Systems)
    • 4.5.1. Smart Infusion Pumps (Infusion Systems) Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
      • 4.5.1.1. Non-biologic Smart Infusion Systems
        • 4.5.1.1.1. Non-biologic Smart Infusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
      • 4.5.1.2. Biologic Smart Infusion Systems
        • 4.5.1.2.1. Biologic Smart Infusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
          • 4.5.1.2.1.1. Smart Infusion Insulin Pumps
            • 4.5.1.2.1.1.1. Smart Infusion Insulin Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
          • 4.5.1.2.1.2. Others
            • 4.5.1.2.1.2.1. Others Market Revenue Estimated and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 4.6. Smart Metered Dose Inhalers (Inhalation Devices)
    • 4.6.1. Smart Metered Dose Inhalers (Inhalation Devices) Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 4.7. Implantable Drug Delivery Devices
    • 4.7.1. Implantable Drug Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
      • 4.7.1.1. Biologic Implantable Drug Delivery Devices
        • 4.7.1.1.1. Biologic Implantable Drug Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
      • 4.7.1.2. Non-biologic Implantable Drug Delivery Devices
        • 4.7.1.2.1. Non-biologic Implantable Drug Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 5. Electronic Drug Delivery Devices Market: Application Estimated & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Electronic Drug Delivery Devices Market: Application Movement Analysis
  • 5.3. Electronic Drug Delivery Devices Market by Application Outlook (Revenue, USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Diabetes
    • 5.5.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Respiratory Diseases
    • 5.6.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. Oncology
    • 5.7.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.8. Cardiology
    • 5.8.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Electronic Drug Delivery Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Regional Electronic Drug Delivery Devices Market Movement Analysis
  • 6.3. Electronic Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Product
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. North America
    • 6.5.1. North America Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. U.S. Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. Canada Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement scenario
      • 6.5.4.5. Mexico Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Europe
    • 6.6.1. Europe Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. UK
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. UK Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Germany Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.4. France
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement scenario
      • 6.6.4.5. France Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement scenario
      • 6.6.5.5. Italy Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement scenario
      • 6.6.6.5. Spain Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.7. Denmark
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement scenario
      • 6.6.7.5. Denmark Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Competitive Scenario
      • 6.6.8.3. Regulatory Framework
      • 6.6.8.4. Reimbursement scenario
      • 6.6.8.5. Sweden Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.9. Norway
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Competitive Scenario
      • 6.6.9.3. Regulatory Framework
      • 6.6.9.4. Reimbursement scenario
      • 6.6.9.5. Norway Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Asia Pacific Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Japan
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Japan Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. China
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. China Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. India
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. India Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. South Korea Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.6. Australia
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory Framework
      • 6.7.6.4. Reimbursement scenario
      • 6.7.6.5. Australia Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.7. Thailand
      • 6.7.7.1. Key Country Dynamics
      • 6.7.7.2. Competitive Scenario
      • 6.7.7.3. Regulatory Framework
      • 6.7.7.4. Reimbursement scenario
      • 6.7.7.5. Thailand Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.8. Latin America
    • 6.8.1. Latin America Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.8.2. Brazil
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. Brazil Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. Argentina Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.9. Middle East & Africa
    • 6.9.1. Middle East & Africa Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.9.2. South Africa
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Competitive Scenario
      • 6.9.2.3. Regulatory Framework
      • 6.9.2.4. Reimbursement scenario
      • 6.9.2.5. South Africa Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.9.3. Saudi Arabia
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Competitive Scenario
      • 6.9.3.3. Regulatory Framework
      • 6.9.3.4. Reimbursement scenario
      • 6.9.3.5. Saudi Arabia Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.9.4. UAE
      • 6.9.4.1. Key Country Dynamics
      • 6.9.4.2. Competitive Scenario
      • 6.9.4.3. Regulatory Framework
      • 6.9.4.4. Reimbursement scenario
      • 6.9.4.5. UAE Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.9.5. Kuwait
      • 6.9.5.1. Key Country Dynamics
      • 6.9.5.2. Competitive Scenario
      • 6.9.5.3. Regulatory Framework
      • 6.9.5.4. Reimbursement scenario
      • 6.9.5.5. Kuwait Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. Medtronic plc
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Insulet Corporation
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Becton, Dickinson and Company
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Tandem Diabetes Care, Inc.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Ypsomed AG
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Novo Nordisk A/S
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Sanofi S.A.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Eli, Lilly and Company
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. AstraZeneca plc
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. GlaxoSmithKline plc
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Boehringer Ingelheim International GmbH
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Pfizer, Inc.
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Teva Pharmaceutical Industries
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Phillips-Medisize, LLC
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
    • 7.2.15. West Pharmaceutical Services, Inc.
      • 7.2.15.1. Company overview
      • 7.2.15.2. Financial performance
      • 7.2.15.3. Product benchmarking
      • 7.2.15.4. Strategic initiatives
    • 7.2.16. Gerresheimer AG
      • 7.2.16.1. Company Overview
      • 7.2.16.2. Financial performance
      • 7.2.16.3. Product benchmarking
      • 7.2.16.4. Strategic initiatives
    • 7.2.17. Nemera Group
      • 7.2.17.1. Company overview
      • 7.2.17.2. Financial performance
      • 7.2.17.3. Product benchmarking
      • 7.2.17.4. Strategic initiatives
    • 7.2.18. SHL Group
      • 7.2.18.1. Company overview
      • 7.2.18.2. Financial performance
      • 7.2.18.3. Product benchmarking
      • 7.2.18.4. Strategic initiatives
    • 7.2.19. Owen Mumford
      • 7.2.19.1. Company overview
      • 7.2.19.2. Financial performance
      • 7.2.19.3. Product benchmarking
      • 7.2.19.4. Strategic initiatives
    • 7.2.20. Haselmeier AG
      • 7.2.20.1. Company overview
      • 7.2.20.2. Financial performance
      • 7.2.20.3. Product benchmarking
      • 7.2.20.4. Strategic initiatives
    • 7.2.21. ICU Medical
      • 7.2.21.1. Company overview
      • 7.2.21.2. Financial performance
      • 7.2.21.3. Product benchmarking
      • 7.2.21.4. Strategic initiatives
    • 7.2.22. Hisamitsu Pharmaceutical Co., Inc.
      • 7.2.22.1. Company overview
      • 7.2.22.2. Financial performance
      • 7.2.22.3. Product benchmarking
      • 7.2.22.4. Strategic initiatives
    • 7.2.23. Sparsha Pharma International
      • 7.2.23.1. Company overview
      • 7.2.23.2. Financial performance
      • 7.2.23.3. Product benchmarking
      • 7.2.23.4. Strategic initiatives
    • 7.2.24. Baxter International, Inc.
      • 7.2.24.1. Company overview
      • 7.2.24.2. Financial performance
      • 7.2.24.3. Product benchmarking
      • 7.2.24.4. Strategic initiatives
    • 7.2.25. Fresenius Kabi AG
      • 7.2.25.1. Company overview
      • 7.2.25.2. Financial performance
      • 7.2.25.3. Product benchmarking
      • 7.2.25.4. Strategic initiatives
    • 7.2.26. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 7.2.26.1. Company overview
      • 7.2.26.2. Financial performance
      • 7.2.26.3. Product benchmarking
      • 7.2.26.4. Strategic initiatives
    • 7.2.27. Novartis AG
      • 7.2.27.1. Company overview
      • 7.2.27.2. Financial performance
      • 7.2.27.3. Product benchmarking
      • 7.2.27.4. Strategic initiatives
    • 7.2.28. AptarGroup, Inc.
      • 7.2.28.1. Company overview
      • 7.2.28.2. Financial performance
      • 7.2.28.3. Product benchmarking
      • 7.2.28.4. Strategic initiatives
    • 7.2.29. Teleflex Incorporates
      • 7.2.29.1. Company overview
      • 7.2.29.2. Financial performance
      • 7.2.29.3. Product benchmarking
      • 7.2.29.4. Strategic initiatives
    • 7.2.30. Abbott Laboratories
      • 7.2.30.1. Company overview
      • 7.2.30.2. Financial performance
      • 7.2.30.3. Product benchmarking
      • 7.2.30.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 4 Global electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 5 North America electronic drug delivery devices market, by region, 2018 - 2030 (Revenue, USD Million)
  • Table 6 North America electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 7 North America electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 8 U.S electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 9 U.S electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 10 Canada electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 11 Canada electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 12 Mexico electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 13 Mexico electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 14 Europe electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
  • Table 15 Europe electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 16 Europe electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 17 UK electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 18 UK electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 19 Germany electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 20 Germany electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 21 France electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 22 France electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 23 Italy electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 24 Italy electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 25 Spain electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 26 Spain electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 27 Norway electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 28 Norway electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 29 Sweden electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 30 Sweden electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 31 Denmark electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 32 Denmark electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 33 Asia Pacific electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
  • Table 34 Asia Pacific electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 35 Asia Pacific electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 36 Japan electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 37 Japan electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 38 China electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 39 China electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 40 India electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 41 India electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 42 Australia electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 43 Australia electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 44 South Korea electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 45 South Korea electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 46 Thailand electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 47 Thailand electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 48 Latin America electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
  • Table 49 Latin America electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 50 Latin America electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 51 Brazil electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 52 Brazil electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 53 Argentina electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 54 Argentina electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 55 Middle East & Africa electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
  • Table 56 Middle East & Africa electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 57 Middle East & Africa electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 58 South Africa electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 59 South Africa electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 60 Saudi Arabia electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 61 Saudi Arabia electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 62 UAE electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 63 UAE electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 64 Kuwait electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
  • Table 65 Kuwait electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Electronic drug delivery devices market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis by Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Electronic drug delivery devices market, product outlook key takeaways (Revenue, USD Million)
  • Fig. 12 Electronic drug delivery devices market: product movement analysis (Revenue, USD Million), 2023 & 2030
  • Fig. 13 Smart infusion pumps (infusion systems) market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 14 Non-biologic smart infusion systems market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 15 Biologic smart infusion systems market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 16 Smart infusion insulin pumps market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 17 Others market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 18 Smart metered dose inhalers (inhalation devices) market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 19 Implantable drug delivery devices market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 20 Biologic implantable drug delivery devices market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 21 Non-biologic implantable drug delivery devices market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 22 Smart transdermal patches (transdermal delivery systems) market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 23 Others market revenue estimates and forecasts, 2018 -2030 (Revenue, USD Million)
  • Fig. 24 Electronic drug delivery devices market, application outlook key takeaways (Revenue, USD Million)
  • Fig. 25 Electronic drug delivery devices market: application movement analysis (Revenue, USD Million), 2023 & 2030
  • Fig. 26 Diabetes market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 27 Respiratory Diseases market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 28 Oncology market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 29 Cardiology market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 30 Others market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 31 Electronic drug delivery devices market: Regional key takeaways (Revenue, USD Million)
  • Fig. 32 Electronic drug delivery devices market: regional outlook, 2023 & 2030, (Revenue, USD Million)
  • Fig. 33 North America electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 34 US electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 35 Canada electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 36 Mexico electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 37 Europe electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 38 UK electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 39 Germany electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 40 France electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 41 Spain electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 42 Italy electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 43 Sweden electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 44 Norway electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 45 Denmark electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 46 Asia Pacific electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 47 China electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 48 Japan electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 49 India electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million
  • Fig. 50 South Korea electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 51 Australia electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 52 Thailand electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 53 Latin America electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 54 Brazil electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 55 Argentina electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 56 Middle East and Africa electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 57 South Africa electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 58 Saudi Arabia electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 59 UAE electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 60 Kuwait electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 61 List of key emerging company's/technology disruptors/innovators